HIGHLIGHTS
- who: Nuria Gutierrez-Prat et al. from the Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland Roche Pharma Research and Early Development, Informatics, Roche Innovation Center Basel, Basel, Switzerland Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland Ridgeline Discovery Basel, Basel, Switzerland Institute of Pharmaceutical Science, King`s College London, London, UK have published the Article: DUSP4 protects BRAF- and NRAS-mutant melanoma from oncogene overdose through modulation of MITF, in the Journal: (JOURNAL)
- what: The authors demonstrate that drug-naive NRAS-mutant . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.